Literature DB >> 6131081

Influence of glycogen on liver density: computed tomography from a metabolic perspective.

A Dwyer, J L Doppman, A J Adams, M E Girton, S S Chernick, M Cornblath.   

Abstract

The liver is a metabolically active organ with a radiographic density that can be modified by its glycogen and fat content. In rhesus monkeys an increase in liver glycogen induced by glucose loading was accompanied by an increase in attenuation values on computed tomography and a decrease in total liver fat. Conversely, fasting depleted glycogen, increased fat, and decreased liver attenuation. Acute glycogen depletion without significant change in fat was induced by administration of glucagon and accompanied by a decrease in attenuation. These results along with in vitro measurements of glycogen solutions suggest that an increase of approximately 3 Hounsfield units can be expected for each percent increase in liver glycogen content.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6131081     DOI: 10.1097/00004728-198302000-00012

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  5 in total

1.  Computed Tomography-Derived Skeletal Muscle Radiodensity Predicts Peak Weight-Corrected Jump Power in Older Adults: The Korean Urban Rural Elderly (KURE) Study.

Authors:  Heewon Choi; Namki Hong; Narae Park; Chang Oh Kim; Hyeon Chang Kim; Jin Young Choi; Yoosik Youm; Yumie Rhee
Journal:  Calcif Tissue Int       Date:  2021-02-10       Impact factor: 4.333

2.  Association between variants in or near PNPLA3, GCKR, and PPP1R3B with ultrasound-defined steatosis based on data from the third National Health and Nutrition Examination Survey.

Authors:  Ruben Hernaez; Jody McLean; Mariana Lazo; Frederick L Brancati; Joel N Hirschhorn; Ingrid B Borecki; Tamara B Harris; Thutrang Nguyen; Ihab R Kamel; Susanne Bonekamp; Mark S Eberhardt; Jeanne M Clark; Wen Hong Linda Kao; Elizabeth K Speliotes
Journal:  Clin Gastroenterol Hepatol       Date:  2013-02-13       Impact factor: 11.382

3.  Relationship between genetic variation at PPP1R3B and levels of liver glycogen and triglyceride.

Authors:  Stefan Stender; Eriks Smagris; Bo K Lauridsen; Klaus F Kofoed; Børge G Nordestgaard; Anne Tybjaerg-Hansen; Len A Pennacchio; Diane E Dickel; Jonathan C Cohen; Helen H Hobbs
Journal:  Hepatology       Date:  2018-04-19       Impact factor: 17.425

4.  Associations of trunk fat depots with insulin resistance, β cell function and glycaemia--a multiple technique study.

Authors:  Anjali Ganpule-Rao; Charudatta Joglekar; Deepak Patkar; Manoj Chinchwadkar; Dattatreya Bhat; Himangi Lubree; Sonali Rege; Bhagyashree Uradey; Chittaranjan Yajnik; John Yudkin
Journal:  PLoS One       Date:  2013-10-08       Impact factor: 3.240

5.  Protein phosphatase 1 regulatory subunit 3B gene variation protects against hepatic fat accumulation and fibrosis in individuals at high risk of nonalcoholic fatty liver disease.

Authors:  Paola Dongiovanni; Marica Meroni; Rosellina M Mancina; Guido Baselli; Raffaela Rametta; Serena Pelusi; Ville Männistö; Anna L Fracanzani; Sara Badiali; Luca Miele; Stefania Grimaudo; Salvatore Petta; Elisabetta Bugianesi; Giorgio Soardo; Silvia Fargion; Jussi Pihlajamäki; Stefano Romeo; Luca Valenti
Journal:  Hepatol Commun       Date:  2018-04-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.